Abstract:Background: C-Myc aberrations confer a more aggressive clinic behavior in diffuse large B-cell lymphoma (DLBCL). Matrine is an alkaloid extracted from Sophora flavescens Ait. It possesses anti-cancer property through inhibiting the cell proliferation and inducing the apoptosis. The present study aimed to explore the underlying mechanisms of matrine in suppressing the cell growth of DLBCL. Methods: The influence of matrine on the viability of cultured DLBCL cell lines SU-DHL-16 and OCI-LY3 cells were determined by CCK-8. Apoptosis and cell cycle were measured by flow cytometry after matrine exposure. Western blot was taken to investigate the expression of activated Caspase-3, cleaved PARP, c-Myc, phospho-c-Myc (Ser62), CaMKIIγ, phospho-CaMKIIγ (Thr287), CDK4 and CDK6 after matrine treatment. Cycloheximide chase analysis was used to determine the c-Myc protein half-lives before and after matrine treatment. Growth salvage analysis was taken by ectopic expression of c-Myc. Results: In cultured DLBCL cells, matrine suppressed cell viability in a concentration and time dependent fashion. Matrine treated SU-DHL-16 and OCI-LY3 cells for 48 h with IC50 value of 1.76 mM and 4.1 mM, respectively. Matrine induced apoptosis through a caspase-independent pathway and caused G0/G1 cell cycle arrest in a concentration dependent manner in DLBCL cells. The protein expression of c-Myc was inhibited while the transcription of c-Myc was not reduced by matrine. c-Myc protein half-lives were decreased from 30.4, 69.4 min to 16.6, 15.9 min after matrine treatment in SU-DHL-16 and OCI-LY3, respectively. As a critical protein kinase of c-Myc, CaMKIIγ phosphorylation at Thr287 was found to be down-regulated and c-Myc phosphorylation at Ser62 was reduced together after matrine treatment in DLBCL. The growth suppression of SU-DHL-16 cells induced by matrine was rescued by over-expression of c-Myc achieved by recombinant adenovirus infection. The decreased expression of CDK6, not CDK4, induced by matrine was rescued by ectopic expression of c-Myc protein. Conclusions: This study has shown for the first time that matrine suppresses cell growth of DLBCL via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway.

Effect of matrine on the proliferation of lymphoma Raji cells and survivin expression

Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

Effect of Matrine on Inhibiting Proliferation and Inducing Apoptosis of Human Intestinum Crassum Carcinoma HT29 Cells

[Effects of Matrine on the Relative Molecules Expression of Proliferation and Apoptosis in K562 Cells].

Effect of P38mapk Activating Matrine-Induced Apoptosis Raji Cells

Effect of Matrine on Proliferation and HIF-1α,VEGF Expression of A549 Cells

Effects of Matrine on the Proliferation of HT29 Human Colon Cancer Cells and Its Antitumor Mechanism.

Matrine Reduces Proliferation of Human Lung Cancer Cells by Inducing Apoptosis and Changing Mirna Expression Profiles

Inhibitory effect of matrine on the in vitro invasiveness of human malignant melanoma cell line A375

[Effects of matrine on proliferation and apoptosis of human renal cell carcinoma cell line GRC-1].

Effects of Matrine on Proliferation and Differentiation in K-562 Cells

Matrine Inhibits Invasiveness and Metastasis of Human Malignant Melanoma Cell Line A375 in Vitro

Effect of Matrine on Cervical Cancer HeLa Cells

Cellular Biological Effects of Matrine on K562 and K562/Vin Cells

Inhibition of Proliferation and Influence of Proto-oncogenes Expression by Matrine in C6 Cell

Matrine Reduces the Proliferation of A549 Cells Via the P53/p21/pcna/eif4e Signaling Pathway

Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway

Matrine's Inhibitory Effect on the Growth of ACHN Human Renal Cell Carcinoma in Vitro and Its Action Mechanism

Growth Suppression Effect of Matrine on Human Lung Cancer Cell Lines in vitro

Effects of Matrine on proliferation and apoptosis of Hela cells in vitro

Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway